Mice Humanized for the EGF Receptor Display Hypomorphic Phenotypes in Skin, Bone, and Heart

    August 2003 in “ Development
    Maria Sibilia, Bettina Wagner, Astrid Hoebertz, Candace E. Elliott, Silvia Marino, Wolfram Jochum, Erwin F. Wagner
    Studysummary In this study, mice engineered to express human EGFR showed tissue-specific growth defects and neurodegeneration rescue, but developed severe heart issues and accelerated bone cell differentiation.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    Mice humanised for the epidermal growth factor receptor (EGFR) displayed hypomorphic phenotypes, including growth retardation and skin and hair defects similar to Egfr-/- mutants, but with rescued neurodegeneration. These hEGFRKI/KI mice, viable up to six months, developed severe heart hypertrophy and semilunar valve abnormalities. They also showed accelerated chondrocyte and osteoblast differentiation, a novel phenotype not previously described. The severity of these phenotypes was linked to the expression levels of the hEGFRKI allele, which was inefficiently expressed in epithelial and bone cells but expressed at higher levels in the brain and heart, indicating tissue-specific effects and a new role for EGFR in bone development.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results